Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme.
van Oosten
M
M
Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands. marijke.van.oosten@rivm.nl
de Greeff
S C
SC
Spanjaard
L
L
Schouls
L M
LM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003140:Communicable Disease Control / Q000458:organization & administration*; D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008586:Meningitis, Pneumococcal / Q000453:epidemiology* / Q000517:prevention & control*; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D011159:Population Surveillance; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D018074:Vaccines, Conjugate / Q000627:therapeutic use
D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate